These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 21907579)

  • 1. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.
    Rollinger JM; Schmidtke M
    Med Res Rev; 2011 Jan; 31(1):42-92. PubMed ID: 19714577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus.
    Mousnier A; Bell AS; Swieboda DP; Morales-Sanfrutos J; Pérez-Dorado I; Brannigan JA; Newman J; Ritzefeld M; Hutton JA; Guedán A; Asfor AS; Robinson SW; Hopkins-Navratilova I; Wilkinson AJ; Johnston SL; Leatherbarrow RJ; Tuthill TJ; Solari R; Tate EW
    Nat Chem; 2018 Jun; 10(6):599-606. PubMed ID: 29760414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance.
    Richter M; Döring K; Blaas D; Riabova O; Khrenova M; Kazakova E; Egorova A; Makarov V; Schmidtke M
    Antiviral Res; 2024 Feb; 222():105810. PubMed ID: 38244889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concise review on hPXR ligand-recognizing residues and structure-based strategies to alleviate hPXR transactivation risk.
    Liu T; Beck JP; Hao J
    RSC Med Chem; 2022 Feb; 13(2):129-137. PubMed ID: 35308029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Quantum Similarity, Chemical Reactivity and Database Screening of 3D Pharmacophores of the Protein Kinases A, B and G from Mycobacterium tuberculosis.
    Morales-Bayuelo A
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28635627
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in the treatment of rhinovirus infections.
    McKinlay MA
    Curr Opin Pharmacol; 2001 Oct; 1(5):477-81. PubMed ID: 11764773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
    Conti C; Proietti Monaco L; Desideri N
    Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
    Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
    Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
    Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
    J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors.
    Wang H; Xiao J; Gao D; Zhang X; Yan H; Gong Z; Sun T; Li S
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1057-9. PubMed ID: 21215622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
    Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders.
    Morley A; Tomkinson N; Cook A; MacDonald C; Weaver R; King S; Jenkinson L; Unitt J; McCrae C; Phillips T
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6031-5. PubMed ID: 21907579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design of antirhinoviral compounds.
    Giranda VL
    Structure; 1994 Aug; 2(8):695-8. PubMed ID: 7994569
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.